Milbank Advises Mandated Lead Arrangers on Financing for Bridgepoint Acquisition of Gambro Healthcare
LONDON, 11 July 2007 – The international law firm Milbank, Tweed, Hadley & McCloy LLP has advised Mandated Lead Arrangers on financing of acquisition of Gambro Healthcare by Bridgepoint.
Milbank’s Leveraged Finance Group advised Mandated Lead Arrangers Dresdner Kleinwort, RBS and GE Commercial Finance on the €564,000,000 senior, second lien and mezzanine facilities in support of the acquisition.
The Milbank team was led by partner Suhrud Mehta and comprised European Counsel, Patrick Holmes, lead associate Phil Gledson as well as associates Melissa Gambol, David Gasperow, Kevin MacLeod, Randy Ali and Dawn Harding.
Milbank worked with its correspondent law firms across Europe to sign and close the financing on the same day in 14 jurisdictions.
Gambro Healthcare is the dialysis care services division of Swedish Gambro Group, the global medical technology company. It was acquired by Bridgepoint from EQT and Investor.
Gambro Healthcare is the second largest corporate provider of dialysis care services in Europe with 155 clinics in 14 countries serving 12,000 patients and with ancillary businesses in South America and Australia. In the current year to 31 December 2007, Gambro Healthcare is expected to generate turnover of SEK 2.3 billion (€246m) and EBITDA of SEK 446 million (€48m). It was formerly part of the Gambro Group which was the subject of a €4.3 billion take private from the Stockholm Stock Exchange in July 2006.
About Milbank
Milbank, Tweed, Hadley & McCloy LLP is a preeminent global law firm that for more than 140 years has provided innovative legal solutions in many of the world’s largest, most complex, “first-ever” corporate transactions and litigation. Our transactional expertise includes capital markets, corporate finance, project finance, acquisition finance, and other major fields of law practice. Milbank litigation teams resolve disputes involving mergers and acquisitions, proxy battles, financings and securities offerings, intellectual property, white collar crime, and corporate restructurings, among others. Our clients range from prominent multinational financial, industrial and commercial enterprises to governments, institutions and individuals. The Firm is headquartered in New York with offices in Beijing, Frankfurt, Hong Kong, London, Los Angeles, Munich, Singapore, Tokyo, and Washington, DC.
The European leveraged finance and high yield practice has been involved in some of the sector’s most exciting and innovative financings. Its clients include market leading investment banks and private equity houses.